China grants conditional approval for Merck's COVID treatment

China has granted conditional approval for the import of Merck's COVID-19 treatment Molnupiravir, China's medical products regulator said on Friday.

which is also known as MSD outside the United States and Canada, is approved to be used in adult patients who have mild to medium COVID infection and a high risk of progressing to severe cases, according to China's National Medical Products Administration.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China COVID cases could double next month, as Merck antiviral gets approvalChina's health service approved an antiviral to treat COVID-19 as one health company estimates the country will see a doubling of its current wave of cases.
Read more »

Covid in China: Countries tighten rules as tourism set to resumeChina is opening its borders after three years - but as Covid cases surge, other countries are wary.
Read more »

U.S. will require airline passengers traveling from China to test negative for Covid
Read more »

U.S. to require Covid tests for travelers coming from ChinaBiden will require anyone flying to the U.S. from China to provide a negative Covid test following a surge of cases there after Beijing eased its zero-Covid rules.
Read more »

US will require negative COVID test for travelers arriving from ChinaThe U.S. announced new COVID-19 testing requirements Wednesday for all travelers from China, joining other nations imposing restrictions because of a surge of infections.
Read more »